openPR Logo
Press release

Global Osteoarthritis Market to Reach worth USD 10582.1 Million by 2023: Regeneron, Abbott, Ampio Pharmaceuticals Inc., Novartis AG, Merck Sharp & Dohme Corp., Pfizer Inc. , Eli Lilly and Company., ABIOGEN PHARMA S.p.A, TissueGene Inc

09-06-2018 11:40 AM CET | Health & Medicine

Press release from: Crystal Market Research - Healthcare

Global Osteoarthritis Market

Global Osteoarthritis Market

The Osteoarthritis Market was worth USD 6425.3 million in the year 2014 and is expected to reach approximately USD 10582.1 million by 2023, while registering itself at a compound annual growth rate (CAGR) of 5.70% during the forecast period. Osteoarthritis is one of the basis type of arthritis, it mainly affects the aged and overweight people. Osteoarthritis is also referred to as degenerative joint disease. Tissues (also known as cartilage) involved in the part where to bone end meet (joint), wear of and get damaged in Osteoarthritis. Knees, hands, spine and hips are the part mostly affected by Osteoarthritis. Rising number of aged people, growing predominance of osteoarthritis and grown expenditure on healthcare services by governments is the reason for booming of Acetic Anhydride Market. The National Institute of Health has predicted the growth in number of aged people in America twofold by 2050 compared to 2015.

Read Full Market data Tables and in-depth TOC on Osteoarthritis Market: https://www.crystalmarketresearch.com/report/osteoarthritis-market .

Industry Brief:
Osteoarthritis Market by Diseases Type (Knee Osteoarthritis, Spine Osteoarthritis, Foot & Ankle Osteoarthritis, Shoulder Osteoarthritis and Hand Osteoarthritis), Treatment (Medication, Surgery, Therapy and Others), Diagnosis (Imaging, Joint fluid analysis and Others) and End-User (Hospital & clinics, Medical institute, Research organization and Others) - Global Industry Analysis & Forecast to 2023

Competitive Insights:
The approach of leading companies to get hold of the Osteoarthritis Market are; Regeneron, Abbott, Ampio Pharmaceuticals Inc., Novartis AG, Merck Sharp & Dohme Corp., Pfizer Inc. , Eli Lilly and Company., ABIOGEN PHARMA S.p.A, TissueGene Inc. and others.

Access Sample Copy of this Report: https://www.crystalmarketresearch.com/report-sample/HC081182 .

Key Growth Factors affecting on Global Market:
The Growth Factors element of Osteoarthritis market is rise in number of aged population across the globe and increase in the obese population. Now-a-days change in lifestyle is one of the reasons for increase in Osteoarthritis disease. Joints are mostly affected it is due to lack of exercise which is also considered as one of the driving element for this market. Low annual income in growing economies and reactions due to the medical procedure involved the market growth can be limited in the predicted period.

The Osteoarthritis Market is segmented as follows-

Osteoarthritis Market, By Diseases Type, Estimates and Forecast, 2014-2023 ($Million)
Knee Osteoarthritis
Spine Osteoarthritis
Foot & Ankle Osteoarthritis
Shoulder Osteoarthritis
Hand Osteoarthritis

Osteoarthritis Market, By Treatment, Estimates and Forecast, 2014-2023 ($Million)
Medication
Surgery
Therapy
Others

Osteoarthritis Market, By Diagnosis, Estimates and Forecast, 2014-2023 ($Million)
Imaging
Joint fluid analysis
Others

Osteoarthritis Market, End-User, Estimates and Forecast, 2014-2023 ($Million)
Hospital & clinics
Medical institute
Research organization
Others

Regional Outlook:
Globally, American region is leading the osteoarthritis market due to large number of osteoarthritis affected people and the full-fledged medical service segment, also changing lifestyle and growth in investment on medical services. Next to America, Europe and Asia Pacific are the leading region in osteoarthritis market. Government’s investment in R&D sector, developed medical services, increased number of affected people, rise in expenditure on medical services are some of the factors predicting the growth of market. Developing countries such as India and China are seen to have a great chance for gaining the market in projected period. Africa has the slightest hold on osteoarthritis market due to poor economic development in some of the countries. Middle East has a large market share due to high budget assignment for medical service and due to advanced medical services available.

Reasons to buy a Exclusive report?
1) An extensive research study on the Global Osteoarthritis market, and its entire ecosystem, describes the market trends, drivers, restraints and opportunities of the Osteoarthritis market.

2) We provide you the longest possible market segmentation based on type of products, procedures and geography and describe the market share region wise.

3) The report gives a bird eyes view on the competitive landscape which includes mergers and acquisitions, collaborations, market strategies, and new product launches.

Click to Buy In-depth TOC “Osteoarthritis Market Exclusive report": https://www.crystalmarketresearch.com/checkout/HC081182

TOC of Osteoarthritis Market:

4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market States and Outlook (2014-2023)
4.1.2. Canada Market States and Outlook (2014-2023)
4.1.3. Mexico Market States and Outlook (2014-2023)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market States and Outlook (2014-2023)
4.2.2. France Market States and Outlook (2014-2023)
4.2.3. UK Market States and Outlook (2014-2023)

5. Osteoarthritis Market, By Diseases Type
5.1. Introduction
5.2. Global Osteoarthritis Revenue and Market Share by Diseases Type (2014-2018)
5.2.1. Global Osteoarthritis Revenue and Revenue Share by Diseases Type (2014-2018)
5.3. Knee Osteoarthritis
5.3.1. Global Knee Osteoarthritis Revenue and Growth Rate (2014-2018)
5.4. Spine Osteoarthritis
5.4.1. Global Spine Osteoarthritis Revenue and Growth Rate (2014-2018)
5.5. Foot & Ankle Osteoarthritis

6. Osteoarthritis Market, By Treatment
6.1. Introduction
6.2. Global Osteoarthritis Revenue and Market Share by Treatment (2014-2018)
6.2.1. Global Osteoarthritis Revenue and Revenue Share by Treatment (2014-2018)
6.3. Medication
6.3.1. Global Medication Revenue and Growth Rate (2014-2018)
6.4. Surgery
6.4.1. Global Surgery Revenue and Growth Rate (2014-2018)

7. Osteoarthritis Market, By Diagnosis
7.1. Introduction
7.2. Global Osteoarthritis Revenue and Market Share by Diagnosis (2014-2018)
7.2.1. Global Osteoarthritis Revenue and Revenue Share by Diagnosis (2014-2018)
7.3. Imaging

8. Osteoarthritis Market, By End-User
8.1. Introduction
8.2. Global Osteoarthritis Revenue and Market Share by End-User (2014-2018)
8.2.1. Global Osteoarthritis Revenue and Revenue Share by End-User (2014-2018)
8.3. Hospital & clinics
8.3.1. Global Hospital & clinics Revenue and Growth Rate (2014-2018)
8.4. Medical institute
8.4.1. Global Medical institute Revenue and Growth Rate (2014-2018)
8.5. Research organization
…CONTINUED FOR TOC

Avail Discounts offers here: https://www.crystalmarketresearch.com/check-discount/HC081182

About Crystal Market Research:
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contacts Us
Judy | 304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
E-mail: sales@crystalmarketresearch.com | Ph: +1-888-213-4282
Web: https://www.crystalmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Osteoarthritis Market to Reach worth USD 10582.1 Million by 2023: Regeneron, Abbott, Ampio Pharmaceuticals Inc., Novartis AG, Merck Sharp & Dohme Corp., Pfizer Inc. , Eli Lilly and Company., ABIOGEN PHARMA S.p.A, TissueGene Inc here

News-ID: 1223873 • Views:

More Releases from Crystal Market Research - Healthcare

Viral Vector And Plasmid Dna Manufacturing Market Outlook 2019 | Business Development | Research Report 2025
Viral Vector And Plasmid Dna Manufacturing Market Outlook 2019 | Business Develo …
Crystal Market Research Present Advance research on - Viral Vector And Plasmid Dna Manufacturing Market, approximates that the Viral Vector And Plasmid Dna Manufacturing Industry size is anticipated to flourish at a significant CAGR in the future. The Viral Vector and Plasmid DNA Manufacturing Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Viral vectors and plasmid DNA manufacturing usually incorporates
Medical Digital Imaging Systems Market | Research Report 2019-2025 | Major Companies, Shimadzu, Koninklijke Philips N.V, Hitachi, GE Healthcare
Medical Digital Imaging Systems Market | Research Report 2019-2025 | Major Compa …
Crystal Market Research Present Advance research on "Medical Digital Imaging Systems Market", approximates that the Medical Digital Imaging Systems Industry size is anticipated to flourish at a significant CAGR in the future. The Medical Imaging is the process and technique of making the visual portrayals of the inside of the body for the purpose of medical intervention and clinical analysis, just as visual portrayal of the functioning of certain tissues (physiology)
Medical Device Complaint Management Market | Research Report 2019-2025 | Major Companies, MasterControl, IQVIA, Biovia, Sparta Systems
Medical Device Complaint Management Market | Research Report 2019-2025 | Major C …
Crystal Market Research Present Advance research on "Medical Device Complaint Management Market", approximates that the Medical Device Complaint Management Industry size is anticipated to flourish at a significant CAGR in the future. The manufacturers of medical gadget must keep record and also track the complaints of customer as per the Quality System Regulation (QSR) characterized in the 21 CFR Part 820. Furthermore, the FDA Part 803 guidelines need the firms
Veterinary Molecular Diagnostics Market | Research Report 2019-2025 | Major Companies, HealthGene Corporation, Thermo Fisher Scientific Inc, Bioneer, IDEXX Laboratories Inc
Veterinary Molecular Diagnostics Market | Research Report 2019-2025 | Major Comp …
The Universal Veterinary Molecular Diagnostics Market is anticipated to observe supported development over the foreseen period. The major development factor for the growth of Veterinary Molecular Diagnostics is the positive development in the beverage sector. Moreover, expanding canned food preference and increment in extra cash of the customers is the primary factors which are driving the market. Moreover, high recovery and recycling rate of the metal cans is anticipated to

All 5 Releases


More Releases for Osteoarthritis

Osteoarthritis Therapeutics Market: Rising Obese and Geriatric Populations to In …
Industry is experiencing significant growth due to the rapid growth in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease. Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment is likely to hamper the growth of the market. What the Osteoarthritis Therapeutics Market Looks Like? The osteoarthritis therapeutics market is projected to reach USD 10.1 billion by 2024 from USD 6.8
Osteoarthritis Treatment Market by Product (Drugs, Hyaluronic acid Injection) by …
Global Osteoarthritis Treatment Market was valued at USD XX Billion in the year 2017. Global Osteoarthritis Treatment Market is further estimated to grow at a CAGR of XX % from 2018 to reach USD XX Billion by the year 2023. Get Free Access to Sample Report @ https://genesismarketinsights.com/Sample_Request/GENRE369 North America region holds the highest market share in 2017 and is considered as the fastest growing market in the forecasted period. At a
Osteoarthritis-Pipeline Review H2 2017
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis-Pipeline Review, H2 2017, provides an overview of the Osteoarthritis (Musculoskeletal Disorders) pipeline landscape. Osteoarthritis (OA) is one of the most common forms of arthritis. It is a chronic condition in which the cartilage breaks down. Symptoms of osteoarthritis include sore or stiff joints, pain that is worse after activity, bone spurs and grating sensation. Risk factors include older age, joint
Osteoarthritis - Pipeline Review, H2 2017
Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis - Pipeline Review, H2 2017, provides an overview of the Osteoarthritis (Musculoskeletal Disorders) pipeline landscape. Osteoarthritis (OA) is one of the most common forms of arthritis. It is a chronic condition in which the cartilage breaks down. Symptoms of osteoarthritis include sore or stiff joints, pain that is worse after activity, bone spurs and grating sensation. Risk factors include older
Osteoarthritis - Pipeline Review, H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis - Pipeline Review, H1 2017, provides an overview of the Osteoarthritis (Immunology) pipeline landscape. Osteoarthritis (OA) is one of the most common forms of arthritis. It is a chronic condition in which the cartilage breaks down. Symptoms of osteoarthritis include sore or stiff joints, pain that is worse after activity, bone spurs and grating sensation. Risk factors include older age, joint injuries
Osteoarthritis-Pipeline by Review H2 2017
ReportsWeb.com has announced the addition of the “Osteoarthritis-Pipeline Review H2 2017” this report provides an overview of the Osteoarthritis (Musculoskeletal Disorders) pipeline landscape. Osteoarthritis (OA) is one of the most common forms of arthritis. It is a chronic condition in which the cartilage breaks down. Symptoms of osteoarthritis include sore or stiff joints, pain that is worse after activity, bone spurs and grating sensation. Risk factors include older age, joint injuries